The 36-month beta value for SGRY is at 1.94. Analysts have varying views on the stock, with 8 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for SGRY is 75.90M, and currently, shorts hold a 12.34% of that float. The average trading volume for SGRY on June 17, 2025 was 993.03K shares.
SGRY) stock’s latest price update
Surgery Partners Inc (NASDAQ: SGRY)’s stock price has decreased by -14.22 compared to its previous closing price of 23.17. However, the company has seen a -14.77% decrease in its stock price over the last five trading sessions. reuters.com reported 2025-06-17 that Surgery Partners said on Tuesday it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take the surgical facility operator private.
SGRY’s Market Performance
SGRY’s stock has fallen by -14.77% in the past week, with a monthly drop of -16.98% and a quarterly drop of -18.44%. The volatility ratio for the week is 1.46% while the volatility levels for the last 30 days are 1.34% for Surgery Partners Inc The simple moving average for the last 20 days is -13.29% for SGRY stock, with a simple moving average of -20.53% for the last 200 days.
Analysts’ Opinion of SGRY
Many brokerage firms have already submitted their reports for SGRY stocks, with BofA Securities repeating the rating for SGRY by listing it as a “Buy.” The predicted price for SGRY in the upcoming period, according to BofA Securities is $30 based on the research report published on December 16, 2024 of the previous year 2024.
UBS, on the other hand, stated in their research note that they expect to see SGRY reach a price target of $38. The rating they have provided for SGRY stocks is “Buy” according to the report published on October 14th, 2024.
SGRY Trading at -11.17% from the 50-Day Moving Average
After a stumble in the market that brought SGRY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.49% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SGRY starting from Baldock Jennifer, who sale 612 shares at the price of $23.94 back on Mar 14 ’25. After this action, Baldock Jennifer now owns 236,047 shares of Surgery Partners Inc, valued at $14,651 using the latest closing price.
Burkhalter Danielle, the Chief Human Resources Officer of Surgery Partners Inc, sale 74 shares at $23.78 during a trade that took place back on Mar 14 ’25, which means that Burkhalter Danielle is holding 44,839 shares at $1,760 based on the most recent closing price.
Stock Fundamentals for SGRY
Current profitability levels for the company are sitting at:
- 0.11 for the present operating margin
- 0.23 for the gross margin
The net margin for Surgery Partners Inc stands at -0.06. The total capital return value is set at 0.05. Equity return is now at value -10.43, with -2.59 for asset returns.
Based on Surgery Partners Inc (SGRY), the company’s capital structure generated 0.69 points at debt to capital in total, while cash flow to debt ratio is standing at 0.07. The debt to equity ratio resting at 2.22. The interest coverage ratio of the stock is 1.55.
Currently, EBITDA for the company is 501.4 million with net debt to EBITDA at 7.42. When we switch over and look at the enterprise to sales, we see a ratio of 1.95. The receivables turnover for the company is 5.56for trailing twelve months and the total asset turnover is 0.4. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.89.
Conclusion
In conclusion, Surgery Partners Inc (SGRY) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
